The Enterprise Value as of December 2025 (TTM) for Helix BioPharma Corp. (HBPCF) is 178.01M

According to Helix BioPharma Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 178.01M. This represents a change of 812.60% compared to the average of 19.51M of the last 4 quarters.

Helix BioPharma Corp. (HBPCF) Historical Enterprise Value (quarterly & annually)

How has HBPCF Enterprise Value performed in the past?

The mean historical Enterprise Value of Helix BioPharma Corp. over the last ten years is 81.35M. The current 178.01M Enterprise Value has changed 21.78% with respect to the historical average. Over the past ten years (40 quarters), HBPCF's Enterprise Value was at its highest in in the April 2020 quarter at 204.03M. The Enterprise Value was at its lowest in in the January 2025 quarter at 7.22M.

Helix BioPharma Corp. (HBPCF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Helix BioPharma Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Helix BioPharma Corp. (HBPCF) Average Enterprise Value

How has HBPCF Enterprise Value performed in the past?

The current Enterprise Value of Helix BioPharma Corp. (HBPCF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Helix BioPharma Corp. (HBPCF) Enterprise Value vs. Peers

How is HBPCF’s Enterprise Value compared to its peers?

Helix BioPharma Corp.’s Enterprise Value is greater than Relief Therapeutics Holding AG (24.05M), less than Calliditas Therapeutics AB (publ) (11.24B), greater than PsyBio Therapeutics Corp. (135.91K), greater than Relief Therapeutics Holding AG (24.05M), greater than Arch Biopartners Inc. (86.23M), greater than Amplia Therapeutics Limited (53.28M), greater than ZIVO Bioscience, Inc. (39.26M), greater than TransCanna Holdings Inc. (19.70M), greater than Oncotelic Therapeutics, Inc. (58.52M), greater than Vicapsys Life Sciences, Inc. (49.13M),

Build a custom stock screener for Helix BioPharma Corp. (HBPCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Helix BioPharma Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Helix BioPharma Corp. (HBPCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Helix BioPharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.